Understanding the role technology plays in advanced primary care to vulnerable populations is
vital to ensure proper and timely diagnosis and treatment to improve healthcare outcomes for the
patient. The purpose of this assignment is to evaluate one global burden of disease OR risk factor
in the family population (pediatric, adult, or geriatric) and explore one current evidence-based
technology use that can offer improvement of outcomes and access to the population chosen.
Instructions: Please choose one global burden of disease, the population selected is
(PEDIATRIC). Find one evidence-based technology to help support the improvement of
outcomes in the global burden of disease chosen.
Brief overview of the health of the population chosen -Introduce the global burden of disease OR risk factor chosen -Importance of improving the condition and its impact on quality of life
Body of the Paper
Global Burden of Disease Condition/Risk Factor -Describe the disease OR risk factor chosen -What signs/symptoms are identified in the patient that can be found? -How is it diagnosed and trea
Full Answer Section
significant health threat for children under five (IHME, 2024; Wang et al., 2025). These infections, including pneumonia, bronchitis, and bronchiolitis, are primarily caused by viral pathogens like Respiratory Syncytial Virus (RSV) and influenza, as well as bacterial pathogens such as Streptococcus pneumoniae. The burden is particularly heavy in sub-Saharan Africa and South Asia, where limited access to healthcare, malnutrition, and environmental factors exacerbate the problem (UNICEF, 2023).
Importance of Improving the Condition and its Impact on Quality of Life
Improving the diagnosis and treatment of LRIs in children is of paramount importance for several reasons. Firstly, it directly addresses a major cause of preventable child deaths, upholding the fundamental right to life and health. Early and accurate diagnosis enables timely intervention, preventing the progression from mild to severe disease and reducing the need for hospitalization.
Beyond mortality, LRIs significantly impact the quality of life for both affected children and their families. Children suffering from LRIs often experience distressing symptoms such as fever, cough, shortness of breath, and wheezing, leading to discomfort, disturbed sleep, decreased appetite, and reduced participation in play and daily activities (Bindhiya et al., 2025; Little et al., 2019). Severe infections can lead to long-term respiratory consequences, including recurrent wheeze and impaired lung health. For parents and caregivers, a child's illness translates into significant stress, anxiety, missed workdays, and financial strain due to healthcare costs and lost income. In LMICs, this burden can push already vulnerable families further into poverty. Timely and proper management can alleviate suffering, prevent complications, reduce healthcare utilization, and ultimately improve the child's overall well-being and developmental trajectory.
Body of the Paper
Global Burden of Disease Condition/Risk Factor: Lower Respiratory Infections (LRIs)
LRIs encompass a range of acute infections affecting the airways and lungs, below the level of the larynx. The most common and severe LRI in children is pneumonia. Other common LRIs include bronchiolitis and acute bronchitis.
Sample Answer
Understanding the Role of Technology in Advanced Primary Care for Vulnerable Populations: Pediatric Respiratory Infections
Brief Overview of the Health of the Pediatric Population and Global Burden of Disease
The health of the pediatric population, particularly children under five years of age, remains a critical global health concern despite significant advancements in reducing child mortality. Millions of children continue to succumb to preventable and treatable conditions before their fifth birthday, with a disproportionate burden falling on low- and middle-income countries (LMICs).
Global Burden of Disease Chosen: Lower Respiratory Infections (LRIs)
Among the myriad challenges facing pediatric health, Lower Respiratory Infections (LRIs) stand out as a leading cause of morbidity and mortality globally in children under five. In 2021, LRIs accounted for over 500,